CD44 knockdown reduced FGFR2 expression and impaired tumor formation, and the reverse was also observed, as FGFR2 knockdown reduced CD44 levels and stem cell markers, paradoxically increasing c-Myc and SOX-2 [38]. Here, CD44 is linked to neoplasm.